338 related articles for article (PubMed ID: 7534414)
21. Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site.
Cui H; Niemitz EL; Ravenel JD; Onyango P; Brandenburg SA; Lobanenkov VV; Feinberg AP
Cancer Res; 2001 Jul; 61(13):4947-50. PubMed ID: 11431321
[TBL] [Abstract][Full Text] [Related]
22. Loss of imprinting of the IGF2 gene in a Wilms' tumor in an adult.
Oda H; Shimizu S; Minami K; Kaneko K; Ishikawa T
J Natl Cancer Inst; 1997 Dec; 89(23):1813-4. PubMed ID: 9392625
[No Abstract] [Full Text] [Related]
23. Symmetric and asymmetric DNA methylation in the human IGF2-H19 imprinted region.
Vu TH; Li T; Nguyen D; Nguyen BT; Yao XM; Hu JF; Hoffman AR
Genomics; 2000 Mar; 64(2):132-43. PubMed ID: 10729220
[TBL] [Abstract][Full Text] [Related]
24. Loss of the maternal H19 gene induces changes in Igf2 methylation in both cis and trans.
Forné T; Oswald J; Dean W; Saam JR; Bailleul B; Dandolo L; Tilghman SM; Walter J; Reik W
Proc Natl Acad Sci U S A; 1997 Sep; 94(19):10243-8. PubMed ID: 9294195
[TBL] [Abstract][Full Text] [Related]
25. Regulatory mechanisms at the mouse Igf2/H19 locus.
Kaffer CR; Grinberg A; Pfeifer K
Mol Cell Biol; 2001 Dec; 21(23):8189-96. PubMed ID: 11689707
[TBL] [Abstract][Full Text] [Related]
26. Genomic deletion of an imprint maintenance element abolishes imprinting of both insulin-like growth factor II and H19.
Hu JF; Vu TH; Hoffman AR
J Biol Chem; 1997 Aug; 272(33):20715-20. PubMed ID: 9252392
[TBL] [Abstract][Full Text] [Related]
27. Loss of imprinting of igf2 in renal-cell carcinomas.
Oda H; Kume H; Shimizu Y; Inoue T; Ishikawa T
Int J Cancer; 1998 Jan; 75(3):343-6. PubMed ID: 9455791
[TBL] [Abstract][Full Text] [Related]
28. Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor.
Ravenel JD; Broman KW; Perlman EJ; Niemitz EL; Jayawardena TM; Bell DW; Haber DA; Uejima H; Feinberg AP
J Natl Cancer Inst; 2001 Nov; 93(22):1698-703. PubMed ID: 11717330
[TBL] [Abstract][Full Text] [Related]
29. Impact of folic acid intake during pregnancy on genomic imprinting of
Tserga A; Binder AM; Michels KB
FASEB J; 2017 Dec; 31(12):5149-5158. PubMed ID: 28778973
[TBL] [Abstract][Full Text] [Related]
30. Polymorphic functional imprinting of the human IGF2 gene among individuals, in blood cells, is associated with H19 expression.
Giannoukakis N; Deal C; Paquette J; Kukuvitis A; Polychronakos C
Biochem Biophys Res Commun; 1996 Mar; 220(3):1014-9. PubMed ID: 8607783
[TBL] [Abstract][Full Text] [Related]
31. Somatic overgrowth associated with overexpression of insulin-like growth factor II.
Morison IM; Becroft DM; Taniguchi T; Woods CG; Reeve AE
Nat Med; 1996 Mar; 2(3):311-6. PubMed ID: 8612230
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms causing imprinting defects in familial Beckwith-Wiedemann syndrome with Wilms' tumour.
Sparago A; Russo S; Cerrato F; Ferraiuolo S; Castorina P; Selicorni A; Schwienbacher C; Negrini M; Ferrero GB; Silengo MC; Anichini C; Larizza L; Riccio A
Hum Mol Genet; 2007 Feb; 16(3):254-64. PubMed ID: 17158821
[TBL] [Abstract][Full Text] [Related]
33. Selective methylation of CpGs at regulatory binding sites controls NNAT expression in Wilms tumors.
Hubertus J; Zitzmann F; Trippel F; Müller-Höcker J; Stehr M; von Schweinitz D; Kappler R
PLoS One; 2013; 8(6):e67605. PubMed ID: 23825673
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic regulation of Igf2/H19 imprinting at CTCF insulator binding sites.
Yang Y; Hu JF; Ulaner GA; Li T; Yao X; Vu TH; Hoffman AR
J Cell Biochem; 2003 Dec; 90(5):1038-55. PubMed ID: 14624463
[TBL] [Abstract][Full Text] [Related]
35. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour.
Ogawa O; Eccles MR; Szeto J; McNoe LA; Yun K; Maw MA; Smith PJ; Reeve AE
Nature; 1993 Apr; 362(6422):749-51. PubMed ID: 8097018
[TBL] [Abstract][Full Text] [Related]
36. Imprinting mutation in the Beckwith-Wiedemann syndrome leads to biallelic IGF2 expression through an H19-independent pathway.
Brown KW; Villar AJ; Bickmore W; Clayton-Smith J; Catchpoole D; Maher ER; Reik W
Hum Mol Genet; 1996 Dec; 5(12):2027-32. PubMed ID: 8968759
[TBL] [Abstract][Full Text] [Related]
37. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting.
Li X; Adam G; Cui H; Sandstedt B; Ohlsson R; Ekström TJ
Oncogene; 1995 Jul; 11(2):221-9. PubMed ID: 7624139
[TBL] [Abstract][Full Text] [Related]
38. Alterations in the promoter-specific imprinting of the insulin-like growth factor-II gene in Wilms' tumor.
Vu TH; Hoffman A
J Biol Chem; 1996 Apr; 271(15):9014-23. PubMed ID: 8621549
[TBL] [Abstract][Full Text] [Related]
39. Genomic imprinting of IGF2 and H19 in human meningiomas.
Müller S; Zirkel D; Westphal M; Zumkeller W
Eur J Cancer; 2000 Mar; 36(5):651-5. PubMed ID: 10738131
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour.
Astuti D; Latif F; Wagner K; Gentle D; Cooper WN; Catchpoole D; Grundy R; Ferguson-Smith AC; Maher ER
Br J Cancer; 2005 Apr; 92(8):1574-80. PubMed ID: 15798773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
